Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Melanoma, Cutaneous Malignant 1Anxiety Disorders 1

Interventions

Blood Specimen Collection 16Cyclophosphamide 11fludarabine phosphate 10Peripheral Blood Stem Cell Transplantation 10Cyclosporine 10Photochemotherapy 9Biopsy 9Whole-Body Irradiation 8Standard of Care 8Radiotherapy 8Educational Status 8Surgical Procedures, Operative 7Radiosurgery 7Mycophenolic Acid 7Early Intervention, Educational 7Aminolevulinic Acid 7Tomography, Optical Coherence 6Surveys and Questionnaires 6Psychiatric Rehabilitation 6Practice Guidelines as Topic 6Methods 6Melphalan 6Filgrastim 6Sentinel Lymph Node Biopsy 5Magnetic Resonance Spectroscopy 5Busulfan 5Antilymphocyte Serum 5methyl 5-aminolevulinate 4Therapeutics 4Observation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Eye Movement Desensitization Reprocessing × Dermatologic × Clear all
NCT06767332 2025-01-09

FAME

Leiden University Medical Center

Phase NA Recruiting
30 enrolled
Dermatologic

Melanoma, Cutaneous Malignant, Anxiety Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡